Synexa Life Sciences is a diversified biotechnology company manufacturing high value, difficult-to-produce microbial secondary metabolites for pharmaceutical industries. Synexa uses a combination of traditional and proprietary cell culture technologies coupled with advanced automated purification systems in their production process.
